St. Jude Children ’s Research Hospital has a new clinical trial for relapsed leukemia
A specific type of drug-resistant, relapsed pediatric cancer is the focus of a new clinical trial at St. Jude Children's Research Hospital.
The phase I/II clinical trial called RAVEN aims to research a new treatment option for children with relapsed acute lymphoblastic leukemia (ALL) — a severe cancer of blood and bone marrow that attacks white blood cells.
According to Dr. Seth Karol, the trial's principal investigator and St. Jude associate faculty member, RAVEN uses a combination of traditional…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Aishwarya Airy Source Type: news
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Biotechnology | Cancer | Cancer & Oncology | Children | Clinical Trials | Health Management | Hospitals | Leukemia | Pediatrics